39
Participants
Start Date
July 31, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
PF-00446687
Single 200mg dose as an oral solution
Placebo
Placebo for oral solution
Placebo
Placebo for tablet
Sildenafil
Single oral dose 100 mg tablet
PF-00446687
Single 125 mg dose as an oral solution
PF-00446687
Single 175 mg dose as an oral solution
PF-00446687
Single 20 mg dose as an oral solution
Placebo
Placebo for oral solution
Placebo
Placebo for tablet
Sildenafil
Single oral dose 100 mg tablet
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Belfast
Pfizer Investigational Site, Leeds
Lead Sponsor
Pfizer
INDUSTRY